Purple Debt Equity Ratio from 2010 to 2024

PPBT Stock  USD 4.02  0.09  2.19%   
Purple Biotech Debt Equity Ratio yearly trend continues to be comparatively stable with very little volatility. Debt Equity Ratio will likely drop to 0.30 in 2024. From the period from 2010 to 2024, Purple Biotech Debt Equity Ratio quarterly data regression had r-value of (0.57) and coefficient of variation of  6.05. View All Fundamentals
 
Debt Equity Ratio  
First Reported
2010-12-31
Previous Quarter
0.34
Current Value
0.3
Quarterly Volatility
0.02253594
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Purple Biotech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Purple Biotech's main balance sheet or income statement drivers, such as Depreciation And Amortization of 208.9 K, Interest Expense of 2.3 M or Selling General Administrative of 4.6 M, as well as many indicators such as Price To Sales Ratio of 84.89, Dividend Yield of 0.088 or PTB Ratio of 0.49. Purple financial statements analysis is a perfect complement when working with Purple Biotech Valuation or Volatility modules.
  
Check out the analysis of Purple Biotech Correlation against competitors.
For more information on how to buy Purple Stock please use our How to Invest in Purple Biotech guide.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Purple Stock Analysis

When running Purple Biotech's price analysis, check to measure Purple Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Purple Biotech is operating at the current time. Most of Purple Biotech's value examination focuses on studying past and present price action to predict the probability of Purple Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Purple Biotech's price. Additionally, you may evaluate how the addition of Purple Biotech to your portfolios can decrease your overall portfolio volatility.